GlassScriptPhysician profile
Barbara Frazier
NPI 1255426607
$1,402.18
in general payments reported to CMS, 2019-2025
24 companies · $72.20 in 2025
The $72.20 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $334 · 2020: $336 · 2021: $174 · 2022: $207 · 2023: $242 · 2024: $36.89 · 2025: $72.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $257 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $257.14 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $247.34 | 2022-2023 | Veozah, Myrbetriq |
| Pfizer INC. | $122.70 | 2019-2023 | |
| Roche Diagnostics Corporation | $117.53 | 2019-2020 | |
| Duchesnay USA Incorporated | $115.74 | 2019 | |
| Amgen INC. | $92.04 | 2019-2023 | Prolia, Evenity |
| Abbvie INC. | $79.20 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $74.43 | 2019-2020 | |
| Coopersurgical, INC. | $70.65 | 2020-2025 | Paragard T 380a |
| Bausch Health US, LLC | $68.11 | 2019-2021 | |
| Aspira Women'S Health INC | $65.74 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $57.54 | 2019-2021 | |
| Myovant Sciences INC. | $53.75 | 2021-2022 | |
| Ethicon US, LLC | $35.20 | 2020-2025 | Stratafix |
| Novo Nordisk INC | $30.99 | 2020 | |
| Sumitomo Pharma America, INC. | $26.27 | 2023 | Myfembree |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Monaghan Medical Corporation | $19.70 | 2023 | Aeroeclipse |
| Medtronic, INC. | $19.52 | 2024 | Interstim |
| Daiichi Sankyo INC. | $17.42 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.37 | 2024 | |
| Merck Sharp & Dohme LLC | $15.76 | 2025 | Gardasil 9 |
| Radius Health, INC. | $14.76 | 2020 | |
| Hologic Sales and Service, LLC | $14.24 | 2025 | Myosure Tissue Removal Device, Acessa Provu System, Novasure |
| Biohaven Pharmaceuticals, INC. | $13.56 | 2021 | |
| Lupin INC. | $12.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Frazier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.